Rion came into this Q2 2027 earnings print as a value story in a growth market, trading at a P/E that many investors see as discounted and with the stock down 10.4% over the past month. The fresh results show Basic EPS of ¥72.15 and net income of ¥890m, which extends the company’s recent earnings progress. Yet the share price closed at ¥3,055 on October 30 after a weak 7 day stretch. The immediate reaction suggests fatigue, while the income statement points to a business still quietly compounding profits.

Investors who like the earnings power at Rion but are uneasy about the recent 10.4% slide and muted price reaction can check out our list of value stocks with resilient balance sheets and consistent profitability in the list of solid balance sheet and fundamentals stocks (21 results)

Q2 2027 Earnings Summary

• Revenue (Q2 2027 vs. Q2 2026): ¥7,399m vs. ¥6,991.924m (up about 5.8%)
• Net Income (Excl. Extra Items, Q2 2027 vs. Q2 2026): ¥890m vs. ¥855.875m (up about 4.0%)
• Basic EPS (Q2 2027 vs. Q2 2026): ¥72.15 vs. ¥69.44 (up about 3.9%)
• Trailing 12-Month Net Profit Margin (TTM, Q2 2027 vs. Q2 2026): 11.9% vs. 10.9% (margin higher year on year)

Rion’s earnings are rising while its valuation stays low. Ask Charlie what makes Rion look this cheap.

Rion’s Quiet Earnings Progress Supports Themed Growth Story

For anyone leaning toward the “aging society and precision equipment” angle, Rion’s latest quarter keeps that story intact. Revenue sits higher year on year and net income and EPS both move up, even if only by mid single digits. Profit margin on a trailing basis is also stronger. That mix fits a business built on recurring medical and industrial demand rather than breakneck expansion. The share price reaction looks tired, yet the core operations still point in the same direction as the long term healthcare and quality control themes.

Short Term Price Weakness Keeps Risk Debate Alive

Bears can still point to the share price, which has fallen over 5% in a week and about 10% over a month, as a signal of fading enthusiasm. The latest results do not show sharp acceleration that might quickly reverse that mood. At the same time, revenue, earnings and margin all move the right way, which tempers more severe worries about pressure on the business model. For now, Rion’s financial trajectory looks steadier than the recent trading pattern might suggest.

After an unstable dividend track record and a soft share price, it is worth asking what else might be lurking beneath the surface. Review the full risk analysis for Rion which shows 1 important warning sign

Hunt Quiet Mispricings Before They Clear

Rion shows how steady earnings and a hesitant share price can fall out of sync. The real opportunity is finding stocks that could be undervalued before the market corrects them.

• Company 1 - 36% below our estimate - develops and maintains public infrastructure projects as authorities outsource complex construction, seismic reinforcement and environmental remediation work.
• Company 2 - 34% below our estimate - supplies specialty electronic materials that device makers adopt when they upgrade displays, sensors and optical components in their products.
• Company 3 - 39% below our estimate - expands virtual talent management as corporate and government clients shift marketing budgets into VTuber led events and content campaigns.

That is three of the list. See the full list of 15 companies trading below our fair value estimates →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.